Analyst Ratings for iTeos Therapeutics (ITOS) [Buys]

ITOS Rating Summary

ITOS Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ITOS
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $44.75 (+64.9%) * Over Last 12-Mos
Rating Score: 10 / 10   Percentile Rank: 95%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/5/2021 H.C. Wainwright Swayampakula Ramakanth New Coverage Buy
(N/A)
37.00
(N/A)
23.03
(27.14)
17.85% Details
10/7/2020 Baird Michael Ulz New Coverage Outperform
(N/A)
45.00
(N/A)
21.59
(27.14)
25.71% Details
Like ITOS Ratings? Also take a look at GSK

ITOS Ratings News